复星医药上半年净利润24.8亿元，同比增长44.77%_老虎社区_美港股上老虎

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1157840211?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/753c9aba3202037bc97463c545d5d015","is_english":false,"pubTime":"2021-08-23 19:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157840211","market":"hk","top_or_hot":-1,"title":"复星医药上半年净利润24.8亿元，同比增长44.77%","media":"老虎资讯综合","content":"<p>8月23日，<a href=\"https://laohu8.com/S/600196\">复星医药</a>发布2021年上半年业绩。财报显示，上半年营收170亿元，同比增长20.85%，去年同期139.65亿元；上半年净利润24.8亿元，同比增长44.77%，去年同期17.14亿元；上半年每股盈利0.97元，去年同期为0.67元。</p>\n<p>上半年收入保持持续增长、产品结构持续优化：汉曲优、苏可欣、汉利康等新品上市及放量，Gland Pharma营业收入同比大幅增长；持有的BioNTech等金融资产报告期内公允价值上升。</p>\n<p>同日公告，公司拟向天津金耀转让所持有的天津药业25.0011%股权，本次转让价款总额为人民币14.33亿元。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药上半年净利润24.8亿元，同比增长44.77%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药上半年净利润24.8亿元，同比增长44.77%\n</h2>\n\n<h4 class=\"meta\">\n\n2021-08-23 19:13 北京时间&nbsp;&nbsp;&nbsp;<strong>老虎资讯综合</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月23日，复星医药发布2021年上半年业绩。财报显示，上半年营收170亿元，同比增长20.85%，去年同期139.65亿元；上半年净利润24.8亿元，同比增长44.77%，去年同期17.14亿元；上半年每股盈利0.97元，去年同期为0.67元。\n上半年收入保持持续增长、产品结构持续优化：汉曲优、苏可欣、汉利康等新品上市及放量，Gland Pharma营业收入同比大幅增长；持有的BioNTech等...</p>\n\n<a href=\"None\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02196","symbol_name":"复星医药","start_time":0,"source_url":null,"article_id":"1157840211","we_media_id":"102","thumbnails":["https://static.tigerbbs.com/753c9aba3202037bc97463c545d5d015"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157840211","pubTimestamp":1629717228,"sourceInfo":null,"weMediaInfo":{"media_name":"老虎资讯综合","introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"8月23日，复星医药发布2021年上半年业绩。财报显示，上半年营收170亿元，同比增长20.85%，去年同期139.65亿元；上半年净利润24.8亿元，同比增长44.77%，去年同期17.14亿元；上","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600196":"复星医药","02196":"复星医药"},"translate_title":"Shanghai Fosun Pharmaceutical (Group) 's net profit in the first half of the year was 2.48 billion yuan, a year-on-year increase of","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/bf10d18f2f98e0101a246864152a34c0","symbols_score_info":{"600196":0.9,"02196":0.9},"content_text":"8月23日，复星医药发布2021年上半年业绩。财报显示，上半年营收170亿元，同比增长20.85%，去年同期139.65亿元；上半年净利润24.8亿元，同比增长44.77%，去年同期17.14亿元；上半年每股盈利0.97元，去年同期为0.67元。\n上半年收入保持持续增长、产品结构持续优化：汉曲优、苏可欣、汉利康等新品上市及放量，Gland Pharma营业收入同比大幅增长；持有的BioNTech等金融资产报告期内公允价值上升。\n同日公告，公司拟向天津金耀转让所持有的天津药业25.0011%股权，本次转让价款总额为人民币14.33亿元。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[{"id":835204906,"gmtCreate":1629717664805,"gmtModify":1629717664805,"author":{"id":"3539462262177933","authorId":"3539462262177933","name":"听风的歌","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"不知你的疫苗何时能上市场","listText":"不知你的疫苗何时能上市场","text":"不知你的疫苗何时能上市场","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/835204906","repostId":1157840211,"repostType":4,"repost":{"id":"1157840211","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629717228,"share":"https://www.laohu8.com/m/news/1157840211?lang=&edition=full","pubTime":"2021-08-23 19:13","market":"other","language":"zh","title":"复星医药上半年净利润24.8亿元，同比增长44.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157840211","media":"老虎资讯综合","summary":"8月23日，复星医药发布2021年上半年业绩。财报显示，上半年营收170亿元，同比增长20.85%，去年同期139.65亿元；上半年净利润24.8亿元，同比增长44.77%，去年同期17.14亿元；上","content":"<p>8月23日，<a href=\"https://laohu8.com/S/600196\">复星医药</a>发布2021年上半年业绩。财报显示，上半年营收170亿元，同比增长20.85%，去年同期139.65亿元；上半年净利润24.8亿元，同比增长44.77%，去年同期17.14亿元；上半年每股盈利0.97元，去年同期为0.67元。</p>\n<p>上半年收入保持持续增长、产品结构持续优化：汉曲优、苏可欣、汉利康等新品上市及放量，Gland Pharma营业收入同比大幅增长；持有的BioNTech等金融资产报告期内公允价值上升。</p>\n<p>同日公告，公司拟向天津金耀转让所持有的天津药业25.0011%股权，本次转让价款总额为人民币14.33亿元。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药上半年净利润24.8亿元，同比增长44.77%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药上半年净利润24.8亿元，同比增长44.77%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-08-23 19:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>8月23日，<a href=\"https://laohu8.com/S/600196\">复星医药</a>发布2021年上半年业绩。财报显示，上半年营收170亿元，同比增长20.85%，去年同期139.65亿元；上半年净利润24.8亿元，同比增长44.77%，去年同期17.14亿元；上半年每股盈利0.97元，去年同期为0.67元。</p>\n<p>上半年收入保持持续增长、产品结构持续优化：汉曲优、苏可欣、汉利康等新品上市及放量，Gland Pharma营业收入同比大幅增长；持有的BioNTech等金融资产报告期内公允价值上升。</p>\n<p>同日公告，公司拟向天津金耀转让所持有的天津药业25.0011%股权，本次转让价款总额为人民币14.33亿元。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/753c9aba3202037bc97463c545d5d015","relate_stocks":{"600196":"复星医药","02196":"复星医药"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157840211","content_text":"8月23日，复星医药发布2021年上半年业绩。财报显示，上半年营收170亿元，同比增长20.85%，去年同期139.65亿元；上半年净利润24.8亿元，同比增长44.77%，去年同期17.14亿元；上半年每股盈利0.97元，去年同期为0.67元。\n上半年收入保持持续增长、产品结构持续优化：汉曲优、苏可欣、汉利康等新品上市及放量，Gland Pharma营业收入同比大幅增长；持有的BioNTech等金融资产报告期内公允价值上升。\n同日公告，公司拟向天津金耀转让所持有的天津药业25.0011%股权，本次转让价款总额为人民币14.33亿元。","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5623176,"gmtCreate":1629728873884,"gmtModify":1635144438174,"authorId":4088869543384780,"author":{"id":4088869543384780,"authorId":4088869543384780,"name":"猫猫723","avatar":"https://static.tigerbbs.com/6c5060d3e47a8d4bf6b19697a47d2e33","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":835204906,"type":1,"supId":0,"prevId":0,"content":"👍","text":"👍","html":"👍"}],"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":8,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}

复星医药上半年净利润24.8亿元，同比增长44.77%

评论

热议股票

7x24